Teva Pharma Industries Ltd ADR (TEVA)

10.29
+0.10(+0.93%)
  • Volume:
    1,193,383
  • Bid/Ask:
    10.29/10.30
  • Day's Range:
    10.14 - 10.34

TEVA Overview

Prev. Close
10.2
Day's Range
10.14-10.34
Revenue
16.28B
Open
10.2
52 wk Range
8.44-13.3
EPS
-3.63
Volume
1,193,383
Market Cap
11.19B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
7,398,814
P/E Ratio
-
Beta
1.47
1-Year Change
-20.99%
Shares Outstanding
1,102,426,176
Next Earnings Date
Aug 05, 2021
What is your sentiment on Teva Pharma Industries Ltd ADR?
or
Vote to see community's results!

Teva Pharma Industries Ltd ADR News

Teva Pharma Industries Ltd ADR Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyNeutralSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellSell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell

Teva Pharma Industries Ltd ADR Company Profile

Teva Pharma Industries Ltd ADR Company Profile

Employees
37736

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company’s products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Read More
  • why this Junk dont declare bankrupt
    1
    • Worst Trash in Humanity
      1
      • kan ni bu chao jibai
        0
        • kan ni bu chao jibai
          0
          • Shame of Jews
            1
            • Fame of jews to be correct .
              0
          • Why revenue got revised from 3.98?
            0
            • is it possible to watch in-court events in real time somwhere in the web? :D
              0
              • drugmakers go on trial for opioid epidemic in california
                0
                • https://seekingalpha.com/news/3682811-drugmakers-go-on-trial-for-opioid-epidemic-in-california
                  0
                  • tbh Im more and more worried about possible outcomes of opioid trials for teva.
                    0
                    • Teva should be 30-40$ minimum . Bottom. I don’t get it
                      0
                      • yea thats what i though when i bought in 4 years ago.... until the opoid case came and their blockbuster drugs goes expired...
                        0
                    • In my opinion just buy and be patient. Teva is greatly involved with vaccination and other stuff regarding pandemia and I think this will be a good for its PR outlook in not-so-far future, but need patience. Opioid sins aren't yet forgiven:p
                      0
                      • of course they are not interested, it's dead meat.... with the constant incumbency of billions of dollars to pay in lawsuits
                        0
                        • Investors appear not interested in TEVA. Pity. They just received approval for two medications in the EU.
                          0
                          • DJ Pharma setting up nicely though - hopefully this ***can get pulled too - with one two days lag
                            0
                          • At least we get some volume today
                            0
                          • Pulled the plug here - bounce to weak on 11
                            0
                        • Would be nice if we can touch 12 today
                          1
                          • 11,5, I would 13 by April 9th usually a bit optimistic - 16 th then - lol
                            1
                            • 12.00 today ??
                              1
                              • 20 by end of year
                                1
                              • slow and steady toward fair value
                                0
                            • yess !!
                              0
                              • come on Bulls :)
                                0
                                • Buy at 9 again ?
                                  4
                                  • Excellent performance ! Undervalue !!! Should be double-triple.
                                    1
                                    • Indeed one of the worst counter...warren buffett must be overlooked to buy it... Israel company or other foreigner company in USA will never succeed...🙁
                                      8
                                      • Very wrost stocks
                                        0
                                        • Gave up hope on this Israel stock...better declare bankrupt and wound up business...
                                          1
                                          • Hahahahahahha !!! Teva is a 70$ stock . So under value . Good numbers , money machine .
                                            1
                                        • Got to go higher than 11.21 today to indicate bullish...
                                          0
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.